Author:
Reichl Franz-Xaver,Hunder Göran,Liebl Bernhard,Fichtl Burckhard,Forth Wolfgang
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Reference24 articles.
1. Ariyoshi T, Ikeda T (1974) On the tissue distribution and the excretion of arsenic in rats and rabbits after administration with arsenical adducts. J Hyg Chem 20[5]:290–295
2. Bertolero F, Marafante E, Edel Rade J, Pietra R, Sabbioni E (1981) Biotransformation and intracellular binding of arsenic in tissues of rabbits after intraperitoneal administration of 74 arsenic labelled arsenite. Toxicology 20: 35–44
3. Brown SM, Goldstein JL (1990) Drugs used in the treatment of hyper Lipoproteinemias. In: Gilman AG, Rall TW, Alan SN, Taylor P (eds) Goodman and Gilman’s The pharmacological basis of therapeutics. Pergamon Press, New York, Oxford, Bejing, Frankfurt, Sâo Paulo, Sydney, Toronto, Tokyo, pp 874–896
4. Buchet JP, Lauwerys R, Roels H (1981) Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate or dimethylarsinate in man. Int Arch Occup Environ Health 48: 71–79
5. Cooney D (1977) A “supperactive” charcoal for antidotal use in poisonings. Clin Toxicol 11[4]: 387–390
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献